Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
ALX Oncology Holdings ( (ALXO) ) has shared an update.
Sophia Randolph, the Chief Medical Officer of ALX Oncology Holdings Inc., has announced her resignation to seek new professional avenues, effective October 11, 2024. Her departure is amicable, with no disputes over company operations. ALX Oncology is set to look for her replacement and has agreed to a generous separation package for Dr. Randolph, including a lump sum payment, extended health benefits, full vesting of certain stock options, and a consulting agreement to aid in the transition. This move is a forward-looking statement and carries the usual risks associated with such changes in management.
For an in-depth examination of ALXO stock, go to TipRanks’ Stock Analysis page.
